S10 Ep33: Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
OncLive® On Air - Un pódcast de OncLive® On Air
Dr Levy discusses the indication for trastuzumab deruxtecan in HER2+ NSCLC, other ADCs in development, and where the future of ADCs in NSCLC is headed.
